Prenatal diagnosis of the carbohydrate-deficient glycoprotein syndrome type 1A (CDG1A) by a combination of enzymology and genetic linkage analysis after amniocentesis or chorionic villus sampling.
Two pregnancies at risk for the carbohydrate-deficient glycoprotein syndrome Type 1A (CDG1A, phosphomannomutase deficient) were monitored by enzyme and genetic linkage analyses. The index case in both families had a proven deficiency of phosphomannomutase (PMM). An unaffected fetus was predicted in family 1 following amniocentesis. Normal PMM activity was found in cultured amniotic fluid cells and there was no elevation of lysosomal enzymes in the amniotic fluid. Genetic linkage analysis using microsatellite markers closely linked to the CDG1A gene confirmed this prediction. A healthy child was born. In the second family direct assay of chorionic villi showed a profound deficiency of PMM and genetic linkage analysis showed the fetus to have the same haplotype as the proband. The pregnancy was terminated and a deficiency of PMM was confirmed in cultured fibroblasts from the fetus. Reliable prenatal diagnosis of CDG Type 1A (PMM-deficient) can be achieved by a combination of biochemical and molecular genetic tests.
Biochemistry Unit, Institute of Child Health, London, U.K.
J
J
Charlwood
P
P
Clayton
G
G
Keir
N
N
Mian
E
E
Young
B
B
Winchester
D000649:Amniocentesis; D000653:Amniotic Fluid / Q000166:cytology / Q000201:enzymology; D002478:Cells, Cultured; D015193:Chorionic Villi Sampling; D018981:Congenital Disorders of Glycosylation / Q000175:diagnosis*; D005260:Female; D005347:Fibroblasts / Q000201:enzymology; D008040:Genetic Linkage; D006801:Humans; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D018895:Microsatellite Repeats; D010375:Pedigree; D017875:Phosphotransferases (Phosphomutases) / Q000032:analysis / Q000172:deficiency*; D011247:Pregnancy
D017875:Phosphotransferases (Phosphomutases); C052799:phosphomannomutase